In a paradigm shift, a Stanford Medicine-led study reveals a new role for a well-known protein, tau, linked to Alzheimer’s disease and other neurodegenerative disorders.

In a paradigm shift, a Stanford Medicine-led study reveals a new role for a well-known protein, tau, linked to Alzheimer’s disease and other neurodegenerative disorders.

The protein tau is top target for Alzheimer’s drug development, and a new study bolsters those efforts by describing a previously unknown role that tau plays in neurodegeneration.